NTRA Q1 2018 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q1 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$62M+32.9% YoY

Gross Profit

$22M34.9% margin

Operating Income

-$31M-49.0% margin

Net Income

-$33M-52.7% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

+15.9%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$194,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$219M

Total Liabilities

$223M

Stockholders' Equity

-$4M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$47M	+32.9%
Gross Profit	$22M	$13M	+64.7%
Operating Income	-$31M	-$37M	+17.6%
Net Income	-$33M	-$36M	+8.6%

Revenue Segments

Product

$54M44%

Panorama Nipt

$33M27%

Hcs

$18M15%

Licensing And Other

$8M6%

Other Licensing And Other

$7M5%

Other Genetic Tests

$3M2%

Constellation

$1M1%

Geographic Segments

U

$50M81%

E M E A

$9M15%

X

$2M3%

Americas Excluding Us

$850,0001%